Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Bioventus Announced It Has Entered Into A Definitive Agreement To Acquire Misonix In A Cash-And-Stock Transaction. Misonix Stockholders Will Receive Either 1.6839 Shares Of Bioventus Class A Common Stock Or $28 In Cash Without Interest Per Held Share.

Author: Benzinga Newsdesk | July 29, 2021 03:09pm

Posted In: BVS MSON